Mangalam Drugs And Organics Limited — Others, 23-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Mangalam Drugs and Organics Limited has announced a board meeting to discuss the Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2025. The report confirms that the total issued share capital remains at 1.58 crore shares, fully listed on both BSE and NSE, with 100% in dematerialized form. This audit reassures shareholders of the accuracy of capital records, reflecting stability in the company’s financial operations.

Investor sentiment may view this update positively, as it indicates robust compliance and transparency in share management, fostering confidence in future growth.